Document is current
Any future updates will be listed below
-
Authors
Armstrong, April W.
Burne, Rebecca
Bin Sawad, Aseel
Lemyre, Anais
Gauthier-Loiselle, Marjolaine
Guerin, Annie
Vinson, Tanzania
Milovac, Brent
Balu, Sanjeev
-
Funding
Funding for this research was provided by:
LEO Pharma Inc.
- License Information
-
More Information
Article History
Received: 27 January 2026
Accepted: 31 March 2026
First Online: 24 April 2026
Declarations
:
: Aseel Bin Sawad, Tanzania Vinson, Brent Milovac and Sanjeev Balu are employees of LEO Pharma Inc. Rebecca Burne, Anaïs Lemyre, Marjolaine Gauthier-Loiselle, and Annie Guérin are employees of Analysis Group, ULC., a consulting company that has provided paid consulting services to LEO Pharma Inc., which funded the development and conduct of this study and manuscript. April W. Armstrong has served as a consultant or advisory board member, received research grants, honoraria, or other research support from the following companies: AbbVie, Amgen, Beiersdorf, Boehringer Ingelheim (BI), Bristol Myers Squibb (BMS), Dermavant, Galderma, Janssen, LEO Pharma, Lilly, Novartis, Ortho Dermatologics, Pfizer, Regeneron, Sanofi, Sun Pharma, Takeda, and UCB.
: This study was determined to be exempt from IRB review and approval under 45 CFR § 46.104(d)(4) as it involved secondary research using de-identified data. The data were de-identified in accordance with Health Insurance Portability and Accountability Act (HIPAA), 45 CFR § 164.514. Data were obtained under license from Komodo Health ( ).
